BiO2 Medical Raises $12M in Series C Funding
BiO2 Medical, Inc., a San Antonio, Texas-based medical device manufacturer has raised $12m in Series C funding.
The round was led by Remeditex Ventures, with participation from existing investors.
The company intends to use the funding to commercialize the Angel™ Catheter, a central venous catheter and Inferior Vena Cava (IVC) filter combination device, intended to protect against potentially fatal Pulmonary Embolism (PE) in critically ill patients.
Led by Chairman and Chief Executive Officer Christopher E. Banas and Chief Medical Officer Dr. Luis F. Angel, BiO2 Medical has R&D and manufacturing operations in Golden, Colorado.